Activity
-
Education has always been a part of my life. When I was just 12 or 13, I used to help my mom in her tuition classes. At 17, I started teaching 9th…
Education has always been a part of my life. When I was just 12 or 13, I used to help my mom in her tuition classes. At 17, I started teaching 9th…
Liked by Parichay Srivastava
-
Exciting PHUSE news from our Real-World Evidence working group! We initiated a Real-World Evidence Catalyst Challenge: This challenge invites…
Exciting PHUSE news from our Real-World Evidence working group! We initiated a Real-World Evidence Catalyst Challenge: This challenge invites…
Liked by Parichay Srivastava
-
🌿 A Journey of Growth & Influence 🌿 Some days leave a lasting mark—September 26, 2025, was one of them. It wasn’t just another event on the…
🌿 A Journey of Growth & Influence 🌿 Some days leave a lasting mark—September 26, 2025, was one of them. It wasn’t just another event on the…
Liked by Parichay Srivastava
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
University of Lucknow
-
-
Licenses & Certifications
Languages
-
English
-
-
Hindi
-
More activity by Parichay
-
🚨 We're Hiring at Sanofi! 🚨 Biostatistics is leading a quiet revolution in clinical trials. What was once considered a ‘back-end’ function, has…
🚨 We're Hiring at Sanofi! 🚨 Biostatistics is leading a quiet revolution in clinical trials. What was once considered a ‘back-end’ function, has…
Liked by Parichay Srivastava
-
Great first day at #BioSpain! Inspiring to hear what some of the emerging biotech companies are working on. Looking forward to networking at the…
Great first day at #BioSpain! Inspiring to hear what some of the emerging biotech companies are working on. Looking forward to networking at the…
Liked by Parichay Srivastava
-
3 Tennis Balls in one Can, 5 in another. Would you trade one from the left Can for one – or all – from the Right? Certainly not. Because all are not…
3 Tennis Balls in one Can, 5 in another. Would you trade one from the left Can for one – or all – from the Right? Certainly not. Because all are not…
Liked by Parichay Srivastava
-
Had a great time attending and presenting at ConSPIC’25 in Trivandrum! The event featured insightful discussions - ranging from technical advances in…
Had a great time attending and presenting at ConSPIC’25 in Trivandrum! The event featured insightful discussions - ranging from technical advances in…
Liked by Parichay Srivastava
-
🚀 Hackathon 2025 is officially in motion! Our annual hackathon is where creativity collides with collaboration — and this year’s theme, AI…
🚀 Hackathon 2025 is officially in motion! Our annual hackathon is where creativity collides with collaboration — and this year’s theme, AI…
Liked by Parichay Srivastava
-
RECIST (Response Evaluation Criteria in Solid Tumors) is crucial for evaluating the effectiveness of cancer therapies, but it’s not without its…
RECIST (Response Evaluation Criteria in Solid Tumors) is crucial for evaluating the effectiveness of cancer therapies, but it’s not without its…
Liked by Parichay Srivastava
-
We're hiring! We're looking for Associate Directors with a strong tack-record in Health Economics and HTA in both the UK and Rotterdam. If you'd…
We're hiring! We're looking for Associate Directors with a strong tack-record in Health Economics and HTA in both the UK and Rotterdam. If you'd…
Liked by Parichay Srivastava
-
Angelo Tinazzi has been a prolific contributor to PHUSE activities for many years! He is an acclaimed expert on Data Standards including CDISC. A…
Angelo Tinazzi has been a prolific contributor to PHUSE activities for many years! He is an acclaimed expert on Data Standards including CDISC. A…
Liked by Parichay Srivastava
-
I had a unique experience over the weekend - a visit to the office with my family! It might sound unusual, but it turned out to be a delightful…
I had a unique experience over the weekend - a visit to the office with my family! It might sound unusual, but it turned out to be a delightful…
Liked by Parichay Srivastava
-
Some events inform, others inspire …but #PHUSE #SDE #Hyderabad 2025 did both, and more!! Proud to have been a #Gold Sponsor at this incredible event…
Some events inform, others inspire …but #PHUSE #SDE #Hyderabad 2025 did both, and more!! Proud to have been a #Gold Sponsor at this incredible event…
Liked by Parichay Srivastava
Other similar profiles
Explore more posts
-
Immuneel Therapeutics Pvt. Ltd.
Advancing CAR T Conversations in Central India! Immuneel recently hosted the CellSpectrum Esperenza – Nagpur Roundtable Meeting, uniting leading haemato-oncologists from Nagpur and Raipur, both in-person and virtually. The focused discussion centred on the clinical applications of CAR T cell therapy, addressing real-world challenges and opportunities in treating patients with limited conventional options. Through CellSpectrum Esperenza, we aim to: · Facilitate peer exchange on cutting-edge cell therapies · Bring real-world clinical strategies to the forefront · Strengthen our commitment to education and access in next-gen immuno-oncology Together, we are building an ecosystem ready for the future of cancer care. Tanmay Gharat Anil Kamat Dr Nishad Dhakate Rajat Bajaj Dr. Saurabh Prasad Dr Pankaj Dwivedi Dr. Avinash Pophali Avtar krishan Ganju Rahul Arora DIBYENDU DE vishvdeep khushoo #Immuneel #CellSpectrum #Esperenza #CART #Immunotherapy #HaematoOncology #CancerCare #Innovation #Access #OncologyLeadership
3 Comments -
Sheetal Arora
The US move to impose a 100% tariff on imported branded medicines is a challenge, but also an opportunity. In my latest The Economic Times article, I share how this shift could strengthen India’s manufacturing backbone, accelerate self-reliance, and push innovation in biologics, biosimilars, and advanced drug delivery systems. Read here: https://lnkd.in/ghfdbssP #IndianPharma #USTariff #GlobalHealthcare #Innovation #AffordableHealthcare #Policy
24 Comments
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More